Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05737030 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome

Study acronym: LOLAbiome
StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Enrollment target: estimated 55 to confirmed 52 · Study completion date changed from estimate of Dec 2025 to Dec 31, 2025 · Eligibility criteria expanded, about 14 words · 1 more Show 4 more changesShow less
    • Enrollment target: estimated 55 to confirmed 52
    • Study completion date changed from estimate of Dec 2025 to Dec 31, 2025
    • Eligibility criteria expanded, about 14 words
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Recruiting to Active, Not Recruiting Site details revisedv5 Show 1 more changeShow less
    • Site details revised
  3. Primary completion date changed from estimate of Oct 2024 to Jul 23, 2024v4
  4. Primary completion date: Feb 2024 to Oct 2024 Completion date: Jan 2025 to Dec 2025v3 Show 1 more changeShow less
    • Completion date: Jan 2025 to Dec 2025
  5. Secondary endpoints revised (11)v2 See this version in full on ClinicalTrials.gov ↗
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Study to test the effect of the drug "L-ornithine.L-aspertate" (LOLA) on microorganisms in the digestive tract in patients with liver cirrhosis (damage of the liver due to liver disease)
Trial Details
NCT Number NCT05737030
Lead Sponsor Medical University of Graz
Collaborators: CBmed Ges.m.b.H.
Conditions Cirrhosis
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov